科言猫
学术研究的AI总结
首页
文献互助
订阅
我的收藏
科研工具
选题分析
论文总结
专利管理
未登录
返回
C
Chih‐Cheng Lai
chi mei medical center
54
H指数
693
论文数
1.9W
被引数
0
相关解读
订阅
收录论文
365
发表时间
发表时间
IF
被引数
Ocular Safety of Dupilumab Compared With IL-5 Inhibitors in Asthma
与IL-5抑制剂相比,Dupilumab在哮喘中的眼部安全性
Journal of Allergy and Clinical Immunology-In Practice
IF
6.6
2026-09-23
0
PRE
AI
Hsiao-Mei Tsao; Pei-Lun Wu; Ya-Hui Wang; Chao-Hsien Chen; Cheng-Yi Wang; Chih-Cheng Lai; Vin-Cent Wu; Hao-Chien Wang; Hsin-Yi Chen
分享
收藏
Psychiatric Safety of GLP-1 and Dual GIP/GLP-1 Receptor Agonists in Adolescents With Obesity
GLP-1和双重GIP/GLP-1受体激动剂在肥胖青少年中的精神安全性
DIABETES OBESITY & METABOLISM
IF
5.7
2026-09-15
0
PRE
AI
Ting-Hui Liu; Yang-Li Shen; Tien-Hsiang Kuo; Jheng-Yan Wu; Chien-Ho Lin; Chih-Cheng Lai
分享
收藏
Explainable Machine Learning Models for Predicting Functional and Pain Recovery After Fragility Fracture Surgery
脆性骨折手术后功能与疼痛恢复预测的可解释机器学习模型
Diagnostics
IF
3.3
2026-09-08
0
OA
AI
Chien-Hung Chen; Chin-Kai Huang; Chih-Cheng Lai; Li-Chuan Lin; Tai-Hua Yang
分享
收藏
GLP-1 receptor agonists versus SGLT2 inhibitors in patients with coexisting COPD and heart failure
GLP-1受体激动剂与SGLT2抑制剂在合并COPD和心力衰竭患者中的应用比较
Communications Medicine
IF
6.3
2026-08-25
0
OA
AI
Sheng-Chi Huang; Jheng-Yan Wu; Chia-Yu Kuo; Wan-Hsuan Hsu; Ya-Wen Tsai; Chih-Cheng Lai
分享
收藏
Glucagon-like Peptide-1 Receptor Agonists and Risk of Tuberculosis in Type 2 Diabetes
胰高血糖素样肽-1受体激动剂与2型糖尿病患者结核病风险
Nature Communications
IF
15.7
2026-08-22
0
OA
AI
Kuang-Ming Liao; Jheng-Yan Wu; Chih-Cheng Lai
分享
收藏
Risk of falls and delirium associated with dual orexin receptor antagonists versus benzodiazepines and Z-drugs in older adults with dementia
痴呆老年患者中,双 orexin 受体拮抗剂与苯二氮䓬类及 Z-药物相关的跌倒和谵妄风险比较
Translational Psychiatry
IF
6.2
2026-08-20
0
OA
AI
Ting-Hui Liu; Chia-Chun Chu; Chia-Yu Liu; Jheng-Yan Wu; Ya-Wen Tsai; Hsin-An Chang; Chih-Cheng Lai
分享
收藏
Risk of Bone Mineral Density Loss Associated with GLP-1 Receptor Agonists in Overweight COPD Populations [Response to Letter]
GLP-1受体激动剂与超重COPD人群骨密度降低风险的相关性[回复信]
Drug Design Development and Therapy
IF
5.1
2026-08-12
0
OA
AI
Sheng-Chi Huang; Jheng-Yan Wu; Chia-Yu Kuo; Wan-Hsuan Hsu; Ya-Wen Tsai; Chih-Cheng Lai
分享
收藏
Risk of Lymphoma in Patients with Asthma Treated with Dupilumab Compared with Other Biologic Agents: A Retrospective Cohort Study
Chest
IF
8.6
2026-07-28
0
PRE
AI
Kuang-Ming Liao; Sheng Chi Huang; Chia-Yu Kuo; Wan-Hsuan Hsu; Ya-Wen Tsai; Jheng-Yan Wu; Chih-Cheng Lai
分享
收藏
Synergistic activity of mitomycin C in combination with ciprofloxacin against severe Vibrio vulnificus infection
丝裂霉素C与环丙沙星联用对严重创伤弧菌感染的协同活性
Journal of Microbiology Immunology and Infection
IF
3.7
2026-07-27
0
OA
AI
Cheng-Fa Yeh; Chi-Chung Chen; Chih-Cheng Lai; Ping‐Yu Hsu; Jin-Wei Liu; Hung-Jen Tang; Wen-Pin Su
分享
收藏
Clinical outcomes of lean metabolic dysfunction-associated steatotic liver disease by phenotypic subtypes
临床结局在按表型亚型划分的与代谢功能障碍相关的脂肪性肝病
Journal of Gastroenterology
IF
5.5
2026-07-18
0
PRE
AI
Chia-Chih Kuo; Chi-Hsing Chen; Hsing-Tao Kuo; Chih-Cheng Lai
分享
收藏
Comparative dementia risk associated with SGLT2 inhibitors versus DPP-4 inhibitors in patients with type 2 diabetes following traumatic brain injury: A propensity score–matched Cohort study
比较创伤性脑损伤后2型糖尿病患者使用SGLT2抑制剂与DPP-4抑制剂相关的痴呆风险:一项倾向性评分匹配队列研究
Diabetes Research and Clinical Practice
IF
7.4
2026-07-16
0
OA
AI
Yung-De Kuo; Shi-Jun Hung; Chia-Yu Kuo; Chih-Cheng Lai; Jinn-Rung Kuo
分享
收藏
Effectiveness of GLP-1RA vs metformin for diabetes prevention in antipsychotic-treated patients
抗精神病药物治疗患者中GLP-1RA与二甲双胍预防糖尿病的有效性
European Neuropsychopharmacology
IF
6.7
2026-05-02
0
PRE
AI
Ting-Hui Liu; Chung-Han Lee; Chia-Yu Liu; Jheng-Yan Wu; Ya-Wen Tsai; Pei-Hsin Kao; Chih-Cheng Lai
分享
收藏
Methodological Concerns Regarding BMI Imbalance and Competing Risks in a Head-to-Head Comparison of SGLT2 Inhibitors and GLP-1 Receptor Agonists for Incident Dementia
关于SGLT2抑制剂和GLP-1受体激动剂在痴呆新发病例头对头比较中BMI失衡和竞争风险的 方法论问题
diabetes, obesity and metabolism
IF
0
2026-04-15
0
PRE
AI
Shio-Shin Jean; Chih-Cheng Lai
分享
收藏
Sustained effectiveness and safety of esketamine for major depressive disorder: a target trial simulation of real-world data
esketamine对重度抑郁症的持续有效性和安全性:真实世界数据的靶标试验模拟
Translational Psychiatry
IF
6.2
2026-04-10
0
OA
AI
Ting-Hui Liu; Hong-Shiang Shen; Jheng-Yan Wu; Po-Yu Huang; Yu-Ju Shih; Chih-Cheng Lai
分享
收藏
Response to the letter regarding "risk of manic switch and suicidal outcomes in bipolar depression treated with esketamine"
European Neuropsychopharmacology
IF
6.7
2026-01-22
0
PRE
AI
Ting-Hui Liu; Chih-Cheng Lai
分享
收藏
Tirzepatide versus SGLT2 inhibitors for MASLD: a multi-institutional propensity score-matched cohort study
Tirzepatide与SGLT2抑制剂治疗MASLD的比较:一项多中心倾向性评分匹配队列研究
Hepatology International
IF
6.1
2026-01-14
0
PRE
AI
Jheng-Yan Wu; Yu-Min Lin; Wan-Hsuan Hsu; Ting-Hui Liu; Ya-Wen Tsai; Po-Yu Huang; Min-Hsiang Chuang; Tsung Yu; Chih-Cheng Lai
分享
收藏
Association between tirzepatide use and risk of mortality, hospitalization, and suicidal behavior in patients with schizophrenia spectrum disorders: A one-year retrospective cohort study of 3618 patients
利拉鲁肽使用与精神分裂症谱系障碍患者死亡率、住院风险及自杀行为风险之间的关联:一项3618例患者的为期一年的回顾性队列研究
European Neuropsychopharmacology
IF
6.7
2025-12-12
0
PRE
AI
Ting-Hui Liu; Chia-Hsuan Hsu; Jheng-Yan Wu; Po-Yu Huang; Chih-Cheng Chang; Chih-Cheng Lai
分享
收藏
Effectiveness and Safety of High-Dose versus Standard-Dose Cefoperazone-Sulbactam in Severe Infections: A Multicenter Retrospective Study
高剂量与标准剂量头孢哌酮舒巴坦在重症感染中的有效性与安全性:一项多中心回顾性研究
Infection and Drug Resistance
IF
2.9
2025-12-03
0
OA
AI
Cheng-Han Li; Chi-Kuei Hsu; Chih-Cheng Lai; Jin-Wei Liu; Hung-Jen Tang; Kuang-Ming Liao; Ping-Chin Chang; Yee-Huang Ku; Yu-Hsin Chiu; Chien-Tung Chiu
分享
收藏
Methodological Considerations in Assessing the Association Between GLP-1 RA and Pancreatitis
评估GLP-1 RA与胰腺炎关联的方法学考量
AMERICAN JOURNAL OF GASTROENTEROLOGY
IF
7.6
2025-12-01
0
PRE
AI
Jean, Shio-Shin; Lai, Chih-Cheng
分享
收藏
Long-Term Mortality and Cardiorenal Outcomes After Metabolic and Bariatric Surgery in Patients With Type 2 Diabetes and Obesity: A Retrospective Cohort Study
2型糖尿病和肥胖患者代谢与减重手术后的长期死亡率和心肾结局:一项回顾性队列研究
World Journal of Surgery
IF
2.5
2025-12-01
0
PRE
AI
Li, Zi-Ying; Kao, Chia-Li; Liu, Mei-Yuan; Hung, Kuo-Chuan; Lai, Chih-Cheng; Lin, Yu-Min; Wu, Jheng-Yan
分享
收藏
研究方向
暂时未获取到该数据
合作学者
合作期刊
P
Pan‐Chyr Yang
H 指数: 121 · 论文数: 1.4K
P
Po‐Ren Hsueh
H 指数: 106 · 论文数: 1.3K
C
Chong‐Jen Yu
H 指数: 89 · 论文数: 966
Y
Yu‐Hung Chen
H 指数: 84 · 论文数: 224
W
Wen‐Chien Ko
H 指数: 73 · 论文数: 810
查看更多